Literature DB >> 28596383

Reinvestigation of the biological activity of d-allo-ShK protein.

Bobo Dang1, Sandeep Chhabra2, Michael W Pennington3, Raymond S Norton2, Stephen B H Kent4.   

Abstract

ShK toxin from the sea anemone Stichodactyla helianthus is a 35-residue protein that binds to the Kv1.3 ion channel with high affinity. Recently we determined the X-ray structure of ShK toxin by racemic crystallography, in the course of which we discovered that d-ShK has a near-background IC50 value ∼50,000 times lower than that of the l-ShK toxin. This lack of activity was at odds with previously reported results for an ShK diastereomer designated d-allo-ShK, for which significant biological activity had been observed in a similar receptor-blocking assay. As reported, d-allo-ShK was made up of d-amino acids, but with retention of the natural stereochemistry of the chiral side chains of the Ile and Thr residues, i.e. containing d-allo-Ile and d-allo-Thr along with d-amino acids and glycine. To understand its apparent biological activity, we set out to chemically synthesize d-allo-ShK and determine its X-ray structure by racemic crystallography. Using validated allo-Thr and allo-Ile, both l-allo-ShK and d-allo-ShK polypeptide chains were prepared by total chemical synthesis. Neither the l-allo-ShK nor the d-allo-ShK polypeptides folded, whereas both l-ShK and d-ShK folded smoothly under the same conditions. Re-examination of NMR spectra of the previously reported d-allo-ShK protein revealed that diagnostic Thr and Ile signals were the same as for authentic d-ShK. On the basis of these results, we conclude that the previously reported d-allo-ShK was in fact d-ShK, the true enantiomer of natural l-ShK toxin, and that the apparent biological activity may have arisen from inadvertent contamination with trace amounts of l-ShK toxin.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Kv1.3 blocking activity; ShK; allo-Thr/allo-Ile; chemical protein synthesis; peptide chemical synthesis; protein chemistry; protein folding; protein sequence; protein synthesis

Mesh:

Substances:

Year:  2017        PMID: 28596383      PMCID: PMC5535034          DOI: 10.1074/jbc.M117.793943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology.

Authors:  T M Hackeng; J H Griffin; P E Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  A functional role of Rv1738 in Mycobacterium tuberculosis persistence suggested by racemic protein crystallography.

Authors:  Richard D Bunker; Kalyaneswar Mandal; Ghader Bashiri; Jessica J Chaston; Bradley L Pentelute; J Shaun Lott; Stephen B H Kent; Edward N Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

3.  The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.

Authors:  Christine Beeton; Brian J Smith; Jennifer K Sabo; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; K George Chandy; Michael W Pennington; Raymond S Norton
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

4.  Cut-open oocyte voltage-clamp technique.

Authors:  E Stefani; F Bezanilla
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

Review 5.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

6.  Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?

Authors:  T E DeCoursey; K G Chandy; S Gupta; M D Cahalan
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

7.  Ionisation behaviour and solution properties of the potassium-channel blocker ShK toxin.

Authors:  J E Tudor; M W Pennington; R S Norton
Journal:  Eur J Biochem       Date:  1998-01-15

8.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Authors:  Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael W Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen Griffey; Hans-Guenther Knaus; Gerald T Nepom; George A Gutman; Peter A Calabresi; K George Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

9.  Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment.

Authors:  Jeffrey R Currier; Lynee M Galley; Holger Wenschuh; Vivian Morafo; Silvia Ratto-Kim; Clive M Gray; Leonard Maboko; Michael Hoelscher; Mary A Marovich; Josephine H Cox
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

10.  Contamination of synthetic HuD protein spanning peptide pools with a CMV-encoded peptide.

Authors:  Marieke T de Graaf; Janet W de Beukelaar; Peter C Burgers; Theo M Luider; Jaco Kraan; Peter A Sillevis Smitt; Jan W Gratama
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

View more
  1 in total

Review 1.  Novel protein science enabled by total chemical synthesis.

Authors:  Stephen B H Kent
Journal:  Protein Sci       Date:  2018-12-18       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.